These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6132126)

  • 1. Serious reactions to corticotropin-releasing factor.
    Hermus A; Raemaekers JM; Pieters GF; Bartelink AK; Smals AG; Kloppenborg PW
    Lancet; 1983 Apr; 1(8327):776. PubMed ID: 6132126
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis.
    Feuillan P; Poth M; Reilly W; Bright G; Loriaux DL; Chrousos GP
    J Pediatr; 1986 Aug; 109(2):363-6. PubMed ID: 3016223
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
    Schlaghecke R; Kornely E; Santen RT; Ridderskamp P
    N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of corticotropin-releasing factor.
    Hermus A; Raemaekers JM; Peters GF; Bartelink AK; Smals AG; Kloppenborg PW
    Lancet; 1983 Jul; 2(8341):112. PubMed ID: 6134953
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticotropin-releasing-factor induced pituitary-adrenal response in depression.
    Holsboer F; Gerken A; Steiger A; Benkert O; Müller OA; Stalla GK
    Lancet; 1984 Jan; 1(8367):55. PubMed ID: 6140385
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary-adrenal function during corticosteroid therapy. Learning to live with uncertainty.
    Christy NP
    N Engl J Med; 1992 Jan; 326(4):266-7. PubMed ID: 1727980
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of one-time stress on the reactivity of the hypophyseal-adrenal cortical system to corticotropin-releasing factor and vasopressin in rats].
    Podvigina TT
    Ross Fiziol Zh Im I M Sechenova; 1999 Mar; 85(3):462-5. PubMed ID: 10494599
    [No Abstract]   [Full Text] [Related]  

  • 8. Pavlovian conditioning of corticotropin-releasing factor-induced increase of blood pressure and corticosterone secretion in the rat.
    Kreutz M; Hellhammer D; Murison R; Vetter H; Krause U; Lehnert H
    Acta Physiol Scand; 1992 May; 145(1):59-63. PubMed ID: 1502913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CRH receptor: evaluation of the receptor functions].
    Horiba N; Suda T
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():472-5. PubMed ID: 9172569
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovine corticotropin releasing hormone stimulation test: normal value study.
    Young WF; Zinsmeister AR; Twomey CK; Kao PC; Jiang NS; Carpenter PC
    Mayo Clin Proc; 1990 Jul; 65(7):943-8. PubMed ID: 2165546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis stress test in patients with early RA: role of corticotropin-releasing hormone promoter polymorphisms.
    Malysheva O; Wagner U; Wahle M; Pierer M; Wagner U; Stalla GK; Baerwald CG
    Ann Rheum Dis; 2011 Nov; 70(11):2058-9. PubMed ID: 21666229
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined corticotropin-releasing hormone-vasopressin test: a new test for the evaluation of the pituitary adrenal system.
    Späth-Schwalbe E; Fehm HL; Born J; Pfeiffer EF
    Horm Metab Res; 1987 Dec; 19(12):665-6. PubMed ID: 2831128
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucocorticoid therapy and pituitary-adrenal responses to corticotropin-releasing hormone.
    Hägg E; Asplund K; Lithner F
    N Engl J Med; 1992 Jul; 327(4):282; author reply 283-4. PubMed ID: 1614479
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucocorticoid therapy and pituitary-adrenal responses to corticotropin-releasing hormone.
    Axelrod L
    N Engl J Med; 1992 Jul; 327(4):282-3; author reply 283-4. PubMed ID: 1614480
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothalamus-pituitary-adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats.
    Raone A; Cassanelli A; Scheggi S; Rauggi R; Danielli B; De Montis MG
    Neuroscience; 2007 Jun; 146(4):1734-42. PubMed ID: 17481824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of corticotropin releasing hormone.
    Daughaday WH
    Mayo Clin Proc; 1990 Jul; 65(7):1026-8. PubMed ID: 2165545
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition by dexamethasone of the in vivo pituitary response to corticotropin-releasing factor (CRF).
    Russell SM; Dhariwal AP; McCann SM; Yates FE
    Endocrinology; 1969 Sep; 85(3):512-21. PubMed ID: 4307361
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.